Hester Biosciences schedules investor conference call for May 15, 2026 post Q4 and FY2026 results announcement.
Management participants include CEO Rajiv Gandhi, ED Priya Gandhi, and CFO Ashish Desai for the interaction.
ICICI Securities coordinates the call with multiple contact points for investor queries and clarifications.
Disclosure made under SEBI Listing Regulations Regulation 30 for mandatory corporate event intimation.